Skip to Main content Skip to Navigation
Journal articles

Pharmacological characterization of six trkB antibodies reveals a novel class of functional agents for the study of the BDNF receptor

Abstract : BACKGROUND AND PURPOSE: By interacting with trkB receptors, brain-derived neurotrophic factor (BDNF) triggers various signalling pathways responsible for neurone survival, differentiation and modulation of synaptic transmission. Numerous reports have implicated BDNF and trkB in the pathogenesis of various central nervous system affections and in cancer, thus representing trkB as a promising therapeutic target. In this study, we used an antibody-based approach to search for trkB-selective functional reagents. EXPERIMENTAL APPROACH: Six commercially available polyclonal and monoclonal antibodies were tested on recombinant and native, human and rodent trkB receptors. Functional and pharmacological characterization was performed using a modified version of the KIRA-elisa method and radioligand binding studies. Western blot analyses and neurite outgrowth assays were carried out to determine the specificity and selectivity of antibody effects. The survival properties of one antibody were further assessed on cultured neurones in a serum-deprived paradigm. KEY RESULTS: The functional trkB-selective antibodies showed distinct pharmacological profiles, ranging from partial agonists to antagonists, acting on trkB receptors through allosteric modulations. The same diversity of effects was observed on the mitogen-activated protein kinase signalling pathway downstream of trkB and on the subsequent neurite outgrowth. One antibody with partial agonist activity demonstrated cell survival properties by activating the Akt pathway. Finally, these antibodies were functionally validated as true trkB-selective ligands because they failed activating trkA or trkC, and contrary to BDNF, none of them bind to p75(NTR). CONCLUSIONS AND IMPLICATIONS: These trkB-selective antibodies represent a novel class of pharmacological tools to explore the pathophysiological roles of trkB and its potential therapeutic relevance for the treatment of various disorders.
Complete list of metadata

Cited literature [41 references]  Display  Hide  Download
Contributor : Maxim Cazorla Connect in order to contact the contributor
Submitted on : Monday, February 10, 2020 - 9:47:06 AM
Last modification on : Saturday, June 25, 2022 - 9:02:54 PM

Links full text



Maxime Cazorla, J M Arrang, J Prémont. Pharmacological characterization of six trkB antibodies reveals a novel class of functional agents for the study of the BDNF receptor. British Journal of Pharmacology, Wiley, 2011, ⟨10.1111/j.1476-5381.2010.01094.x⟩. ⟨inserm-02472205⟩



Record views